Effects of ethanolic extract from Radix Scrophulariae on ventricular remodeling in rats

Phytomedicine

Volumn 19, Issue 3-4, 2012, Pages 193-205

  Huang, Xiao Yan ^a   Chen, Chang Xun ^a   Zhang, Xue Mei ^a   Liu, Ying ^a   Wu, Xi Min ^a   Li, Yi Ming ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Coronary artery ligation; Ethanolic extract; Radix Scrophulariae; Rat; Ventricular remodeling

Indexed keywords

ALCOHOL; ALDOSTERONE; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; CAPTOPRIL; CARDIOVASCULAR AGENT; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN 1; EOSIN; ETHANOLIC EXTRACT OF RADIX SCROPHULARIAE; GELATINASE A; HEMATOXYLIN; HYDROXYPROLINE; MESSENGER RNA; PICRIC ACID; PLANT EXTRACT; RENIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG EFFICACY; DRUG MECHANISM; HEART LEFT VENTRICLE; HEART MUSCLE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICULAR REMODELING; HEART WEIGHT; MALE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCROPHULARIACEAE; STAINING;

ANGIOTENSIN II; ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOOD CHEMICAL ANALYSIS; CAPTOPRIL; CARDIOMEGALY; COLLAGEN; CORONARY VESSELS; ENDOTHELIN-1; ETHANOL; GENE EXPRESSION REGULATION; HEMODYNAMICS; HYDROXYPROLINE; MALE; MATRIX METALLOPROTEINASE 2; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; ORGAN SIZE; PLANT EXTRACTS; PLANT ROOTS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER; SCROPHULARIA; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR REMODELING;

RATTUS;

EID: 84857052737     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2011.09.079     Document Type: Article

References (35)

1. G. Agnoletti, A. Cargnoni, L. Agnoletti, M. Di Marcello, P. Balzarini, E. Pasini, G. Gitti, P. Martina, R. Ardesi, and R. Ferrari Experimental ischemic cardiomypathy: insights into remodeling, physiological adaptation, and humoral response Ann. Clin. Lab. Sci. 36 2006 333 340 (PubMed:16951276) (Pubitemid 44320429)
2. P. Anversa, C. Beghi, Y. Kikkawa, and G. Olivetti Myocardial response to infarction in the rat. Morphometric measurement of infarct size and myocyte cellular hypertrophy Am. J. Pathol. 118 1985 484 492 (PubMed: 3976847) (Pubitemid 15149815)
3. W.S. Bradham, B. Bozkurt, H. Gunasinghe, D. Mann, and F.G. Spinale Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective Cardiovasc. Res. 53 2002 822 830 (PubMed:11922892) (Pubitemid 34261020)
4. G.L. Brower, J.D. Gardner, M.F. Forman, D.B. Murray, T. Voloshenyuk, S.P. Levick, and J.S. Janicki The relationship between myocardial extracellular matrix remodeling and ventricular function Eur. J. Cardiothorac. Surg. 30 2006 604 610 (PubMed:16935520) (Pubitemid 44332949)
5. G.L. Brower, S.P. Levick, and J.S. Janicki Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure Am. J. Physiol. Heart Circ. Physiol. 292 2007 H3057 H3064 (PubMed:17308006)
6. B.S. Burlew, and K.T. Weber Cardiac fibrosis as a cause of diastolic dysfunction Herz 27 2002 92 98 (PubMed:12025467) (Pubitemid 34309394)
7. M.C. Fishbein, D. Maclean, and P.R. Maroko Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution Am. J. Pathol. 90 1978 57 70 (PubMed:619696) (Pubitemid 8257477)
8. I. Frolkis, J. Gurevitch, Y. Yuhas, A. Iaina, Y. Wollman, T. Chernichovski, Y. Paz, M. Matsa, D. Pevni, A. Kramer, I. Shapira, and R. Mohr Interaction between paracrine tumor necrosis factor-alpha and paracrine angiotensin II during myocardial ischemia J. Am. Coll. Cardiol. 37 2001 316 322 (PubMed:11153758) (Pubitemid 32051756)
9. W. Grossman Diastolic dysfunction and congestive heart failure Circulation 81 1990 III1 III7 (PubMed:2137051)
10. A. Gurlek, M. Kilickap, I. Dincer, R. Dandachi, H. Tutkak, and D. Oral Effect of losartan on circulating TNF alpha levels and left ventricular systolic performance in patients with heart failure J. Cardiovasc. Risk 8 2001 279 282 (PubMed:11702033) (Pubitemid 33010687)
11. W.L. Gu, C.X. Chen, Q. Wu, J. Lü, Y. Liu, and S.J. Zhang Effects of Chinese herb medicine Radix Scrophulariae on ventricular remodeling Pharmazie 65 2010 770 775 (PubMed:21105581)
12. C. Hall, J.L. Rouleau, L. Moy, J. de Champlain, D. Bichet, M. Klein, B. Sussex, M. Packer, J. Rouleau, and M.O. Arnold N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction Circulation 89 1994 1934 1942 (PubMed:8181115)
13. S. Heeneman, J.P. Cleutjens, B.C. Faber, E.E. Creemers, R.J. Suylen, E. Lutgens, K.B. Cleutjens, and M.J. Daemen The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis J. Pathol. 200 2003 516 525 (PubMed:12845619) (Pubitemid 36818252)
14. K. Ji, M. Minakawa, K. Fukui, Y. Suzuki, and I. Fukuda Increased superoxide radical with a decrease in vascular endothelial growth factor and inducible nitric oxide synthase level leads to the progression of left ventricular hypertrophy in a pressure-overload rat heart model Ann. Thorac. Cardiovasc. Surg. 14 2008 210 217 (PubMed:18818569)
15. W.B. Kannel Incidence and epidemiology of heart failure Heart Fail. Rev. 5 2000 167 173 (PubMed:16228142)
16. H. Nagase, and J.F. Woessner Jr. Matrix metalloproteinase J. Biol. Chem. 274 1999 21491 21494 (PubMed: 10419448)
17. J.T. Peterson Matrix metalloproteinase inhibitor development and the remodeling of drug discovery Heart Fail. Rev. 9 2004 63 79 (PubMed:14739769) (Pubitemid 38202142)
18. M.A. Pfeffer, E. Braunwald, L.A. Moyé, L. Basta, E.J.J.R. Brown, T.E. Cuddy, B.R. Davis, E.M. Geltman, S. Goldman, G.C. Flaker, M. Klein, G.A. Lamas, M. Packer, J. Rouleau, J.L. Rouleau, J. Rutherford, J.H. Wertheimer, and M. Hawkins Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators N. Engl. J. Med. 327 1992 669 677 (PubMed:1386652)
19. M.A. Pfeffer, J.M. Pfeffer, M.C. Fishbein, P.J. Fletcher, J. Spadaro, R.A. Kloner, and E. Braunwald Myocardial infarct size and ventricular function in rats Circ. Res. 44 1979 503 512 (PubMed:428047) (Pubitemid 9170880)
20. J. Remes Neuroendocrine activation after myocardial infaretion Br. Heart J. 72 1994 s65 s69 (PubMed:7946807)
21. A.J. Riegger Neuroendocrine excitation in heart failure Br. Heart J. 72 1994 s28 s30 (PubMed:7946753)
22. S.L. Rong, Y.J. Wang, X.L. Wang, Y.X. Lu, C. Chang, F.Z. Wang, Q.Y. Liu, X.Y. Liu, Y.Z. Gao, and S.H. Mi Recombinant human growth hormone secreted from tissue-engineered bioartificial muscle improves left ventricular function in rat with acute myocardial infarction Chin. Med. J. 122 2009 2352 2359 (PubMed:20079139)
23. S. Rubattu, S. Sciarretta, V. Valenti, R. Stanzione, and M. Volpe Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases Am. J. Hypertens. 21 2008 733 741 (PubMed:18464748) (Pubitemid 351913612)
24. S. Sakai, T. Miyauchi, M. Kobayashi, I. Yamaguchi, K. Goto, and Y. Sugishita Inhibition of myoeardial endothelin pathway improves long-term survival in heart failure Nature 384 1996 353 355 (PubMed:8934519) (Pubitemid 26408515)
25. K. Sekiguchi, X. Li, M. Coker, M. Flesch, P.M. Barger, N. Sivasubramanian, and D.L. Mann Cross-regulation between the renin-angiotensin system and inflammatory mediators in cardiac hypertrophy and failure Cardiovasc. Res. 63 2004 433 442 (PubMed:15276468) (Pubitemid 38970187)
26. J.N. Sharma, S.A. Abbas, A.P. Yusof, R.P. Shah, and E.K. Gan Tissue kallikrein increases duration of survival after prolonged coronary artery ligation in hypertensive rats Pharmacology 70 2004 201 205 (PubMed:15001821) (Pubitemid 38316490)
27. T. Shinzato, Y. Ohya, M. Nakamoto, A. Ishida, and S. Takishita Beneficial effects of pioglitazone on left ventricular hypertrophy in genetically hypertensive rats Hypertens. Res. 30 2007 863 873 (PubMed:18037780) (Pubitemid 47578249)
28. Y. Sun, and K.T. Weber Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart J. Mol. Cell. Cardiol. 28 1996 851 858 (PubMed:8762025) (Pubitemid 26169296)
29. H.J. Swan Left ventricular dysfunction in ischemic heart disease: fundamental importance of the fibrous matrix Cardiovasc. Drugs Ther. 8 1994 305 312 (PubMed:7947372) (Pubitemid 24245183)
30. Z.W. Tao, Y.W. Huang, Q. Xia, and Q.W. Xu Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction Chin. Med. J. 118 2005 146 154 (PubMed:15667801) (Pubitemid 40227808)
31. H. Wagner, R. Bauer, D. Merlchart, P.-G. Xiao, and A. Staudinger Chromatographic Fingerprint Analysis of Herbal Medicines (TLC and HPLC of Chinese Drugs) vol. II 2011 Springer Wien, New-York pp. 427-437
32. B. Wang, A. Omar, T. Angelovska, V. Drobic, S.G. Rattan, S.C. Jones, and I.M. Dixon Regulation of collagen synthesis by inhibitory Smad7 in cardiac myofibroblasts Am. J. Physiol. Heart Circ. Physiol. 293 2007 H1282 H1290 9PubMed:17513491)
33. K.T. Weber Cardiac interstitium in health and disease: the fibrillar collagen network J. Am. Coll. Cardiol. 13 1989 1637 1652 (PubMed:2656824) (Pubitemid 19145564)
34. A receptor blocker LU 135252 on cardiac remodeling and survival in a hypertensive rat model of chronic heart failure Acta Pharmacol. Sin. 27 2006 1417 1422 (PubMed:17049116) (Pubitemid 44630308)
35. L.A. Zornoff, S.A. Paiva, D.R. Duarte, and J. Spadaro Ventricular remodeling after myocardial infarction: concepts and clinical implications Arq. Bras. Cardiol. 92 2009 150 164 (PubMed:19360249)